"10.1371_journal.pone.0140956","plos one","2015-10-21T00:00:00Z","Enedino Hernández-Torres; Vanessa Wiggermann; Simon Hametner; Tobias R Baumeister; A Dessa Sadovnick; Yinshan Zhao; Lindsay Machan; David K B Li; Anthony Traboulsee; Alexander Rauscher","UBC MRI Research Centre, University of British Columbia, Vancouver, Canada; Department of Pediatrics, University of British Columbia, Vancouver, Canada; Department of Physics and Astronomy, University of British Columbia, Vancouver, Canada; Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria; Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, Canada; Pacific Parkinsons Research Centre, University of British Columbia, Vancouver, Canada; Department of Medicine (Neurology), University of British Columbia, Vancouver, Canada; Centre for Brain Health, University of British Columbia, Vancouver, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; Department of Radiology, University of British Columbia, Vancouver, Canada; Child and Family Research Institute, University of British Columbia, Vancouver, Canada","Conceived and designed the experiments: AR AT DKBL EHT SH. Performed the experiments: EHT VW TRB. Analyzed the data: EHT VW TRB. Contributed reagents/materials/analysis tools: EHT VW RTB YZ AR. Wrote the paper: EHT VW TRB SH YZ ADS LM DKBL AT AR.","The authors have the following interests: DKBL has received research funding from the Canadian Institute of Health Research and the Multiple Sclerosis Society of Canada. He is the Director of the UBC MS/MRI Research Group which has been contracted to perform central analysis of MRI scans for therapeutic trials with Genzyme, Hoffmann-LaRoche, Merck-Serono, Nuron, Perceptives and Sanofi-Aventis. He has also acted as a consultant to Vertex Pharmaceuticals and served on the Data and Safety Advisory Board for Opexa Therapeutics and Scientific Advisory Boards for Novartis, Nuron and Roche. Dr. Traboulsee has received grant support from Roche Pharmaceuticals, Bayer Pharmaceuticals, and honoraria from Teva Innovation, Biogen Idec, EMD Serono, Sanofi-Genzyme. AR has received honoraria from Roche Pharmaceuticals (unrelated to MS). There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","10","Enedino Hernández-Torres","EHT",10,TRUE,5,3,3,10,TRUE,TRUE,FALSE,0,NA,FALSE
